TREATMENT OF CANCERS USING SEPHB4-HSA FUSION PROTEINS Application EP-3941512-A4 European Patent Office 21 Dec 2022
CHIMERIC ANTIGEN RECEPTOR GENE-MODIFIED LYMPHOCYTE HAVING CYTOCIDAL EFFECT Application WO-2018110374-A1 World Intellectual Property Organisation (WIPO) 21 Jun 2018